Related Experiment Videos
Comparative study between iohexol and iopromide for aortofemoral arteriography
L Vlahos1, P Dimakakos, A Moulopoulou
1Department of Radiology, University of Athens, Areteion University Hospital.
Der Radiologe
|December 1, 1987
Summary
Ultravist-300 (iopromide) showed fewer side effects like body heat and pain than Omnipaque (iohexol) during peripheral arteriography in a clinical trial.
Area of Science:
- Radiology and Medical Imaging
- Pharmacology and Pharmaceutical Science
Background:
- Peripheral arteriography is a crucial diagnostic procedure.
- Contrast media are essential for visualizing blood vessels.
Purpose of the Study:
- To compare the safety and tolerability of Omnipaque (iohexol) and Ultravist-300 (iopromide).
- To evaluate patient-reported side effects during peripheral arteriography.
Main Methods:
- A double-blind clinical trial involving 50 patients.
- Direct comparison of iohexol and iopromide for peripheral arteriography.
Main Results:
- Both contrast agents were well tolerated.
- Ultravist-300 (iopromide) resulted in less reported body heat and pain.
- No idiosyncratic reactions or significant blood pressure changes were observed.
Conclusions:
- Ultravist-300 (iopromide) may offer improved patient comfort compared to Omnipaque (iohexol).
- Both contrast media demonstrate a favorable safety profile for peripheral arteriography.